Stuart McIntosh - Concepedia

Author

Stuart McIntosh

Also Known As

Cliona Kirwan, G. Irwin, K Harding, K McGarry, McIntosh, S; id_orcid 0000-0002-4123-9611, McIntosh, Stuart, McIntosh, Stuart A., Natalie Blencowe, O’Donnell C, Richard D. Kennedy

309

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Queen's University Belfast University of Ulster Belfast City Hospital Belfast Health and Social Care Trust North Bristol NHS Trust

About

Stuart McIntosh is an author at Queen's University Belfast specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	306
2	Arts	1	1	13
3	Business	1	1	13
4	Education	1	1	13
5	Engineering	1	1	83

Stuart McIntosh

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study James Glasbey, Adesoji Ademuyiwa, Adewale Adisa, The Lancet Oncology	2021	280
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial Stephen Johnston, Shannon Puhalla, Duncan Wheatley, Journal of Clinical Oncology	2018	224
Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer Karim Fizazi, Celestia S. Higano, Joel B. Nelson, Journal of Clinical Oncology UrologyGenitourinary CancerMedicinePhase IiiPharmacology	2013	213
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study Shelley Potter, Elizabeth J. Conroy, Ramsey I Cutress, The Lancet Oncology	2019	188
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial Jyothis T. George, Rahul Kakkar, Jayne Marshall, The Journal of Clinical Endocrinology & Metabolism	2016	130
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments Stuart McIntosh, Fareeha Alam, Laura E. Adams, The Lancet Oncology	2023	109
Phase 3, randomized, placebo‐controlled study of zibotentan (ZD4054) in patients with castration‐resistant prostate cancer metastatic to bone Joel B. Nelson, Karim Fizazi, Kurt Miller, Cancer	2012	108
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration‐resistant prostate cancer and bone metastases who were pain‐free or mildly symptomatic for pain: a double‐blind, placebo‐controlled, randomized Phase II trial Nicholas D. James, Armelle Caty, Heather Payne, British Journal of Urology	2010	106
Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study Rajiv Dave, Baek Kim, Alona Courtney, British Journal of Cancer	2021	91
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer K. Miller, Judd W. Moul, Martin Gleave, Prostate Cancer and Prostatic Diseases UrologyGenitourinary CancerMedicinePhase IiiOnce-daily Oral Zibotentan	2013	87

Page 1